Abstract
Biotransformation of (-)-α-santonin using Aspergillus parasiticus resulted in the production of 3,4-epoxy-α-santonin, 4,5-dihydro-α-santonin and 1,2-dihydro-α-santonin and 3 minor products and the biological activity of the transformed products was established by antibacterial & antifungal assays. 3,4-epoxy-α-santonin exhibited higher degree of antibacterial and antifungal activity. 4,5-dihydro-α-santonin showed slight increase in the activity, compared to (-)-α-Santonin. 1,2-dihydro-α-santonin is equipotent to the substrate ( (-)-α-Santonin ). This is the first report on the Biotransformation of (-)-α-Santonin by Aspergillus parasiticus and evaluation of the biological activities of the biotransformed products.
Keywords: (-)-α-santonin, biotransformation, Aspergillus parasiticus, 3, 4-epoxy-α-santonin, 4, 5-dihydro-α-santonin, 1, 2-dihydro-α-santonin, antibacterial, Cytotoxic activity, regioselectivity, stereoselectivity, anti-HIV, Spectrometry, NMR Spectrum, Antibacterial Activity, Antifungal Activity
Current Biotechnology
Title:Biotransformation of (-)-α-Santonin by Aspergillus parasiticus and Antimicrobial Efficacy of the Transformed Products
Volume: 1 Issue: 3
Author(s): Busi Siddhardha, Ramakrishna Gadupudi and Mandava Venkata Basaveswara Rao
Affiliation:
Keywords: (-)-α-santonin, biotransformation, Aspergillus parasiticus, 3, 4-epoxy-α-santonin, 4, 5-dihydro-α-santonin, 1, 2-dihydro-α-santonin, antibacterial, Cytotoxic activity, regioselectivity, stereoselectivity, anti-HIV, Spectrometry, NMR Spectrum, Antibacterial Activity, Antifungal Activity
Abstract: Biotransformation of (-)-α-santonin using Aspergillus parasiticus resulted in the production of 3,4-epoxy-α-santonin, 4,5-dihydro-α-santonin and 1,2-dihydro-α-santonin and 3 minor products and the biological activity of the transformed products was established by antibacterial & antifungal assays. 3,4-epoxy-α-santonin exhibited higher degree of antibacterial and antifungal activity. 4,5-dihydro-α-santonin showed slight increase in the activity, compared to (-)-α-Santonin. 1,2-dihydro-α-santonin is equipotent to the substrate ( (-)-α-Santonin ). This is the first report on the Biotransformation of (-)-α-Santonin by Aspergillus parasiticus and evaluation of the biological activities of the biotransformed products.
Export Options
About this article
Cite this article as:
Siddhardha Busi, Gadupudi Ramakrishna and Venkata Basaveswara Rao Mandava, Biotransformation of (-)-α-Santonin by Aspergillus parasiticus and Antimicrobial Efficacy of the Transformed Products, Current Biotechnology 2012; 1 (3) . https://dx.doi.org/10.2174/2211550111201030194
DOI https://dx.doi.org/10.2174/2211550111201030194 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
3D-QSAR Studies on Flavone-8-acetic Acid Derivatives of Aminopeptidase N Inhibitors
Medicinal Chemistry The Role of Transmembrane Segment II in 7TM Receptor Activation
Current Molecular Pharmacology Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Role of Dendritic Cells in HIV-Immunotherapy
Current HIV Research Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Natural-based Hydrogels: A Journey from Simple to Smart Networks for Medical Examination
Current Medicinal Chemistry The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis
Current Molecular Medicine A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2
Current Drug Research Reviews Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Understanding Stem Cell-Mediated Brain Repair Through Neuroimaging
Current Stem Cell Research & Therapy Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Substance P and its Inhibition in Ocular Inflammation
Current Drug Targets The Functions of F-box Proteins in Regulating the Epithelial to Mesenchymal Transition
Current Pharmaceutical Design Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
Current Cancer Drug Targets Botanical Therapeutics (Part II): Antimicrobial and In Vitro Anticancer Activity against MCF7 Human Breast Cancer Cells of Chamomile, Parsley and Celery Alcoholic Extracts
Anti-Cancer Agents in Medicinal Chemistry Managing Skin Malignancies- How Family Doctors, Plastic Surgeons, and Dermatologists Can Help
Current Cancer Therapy Reviews DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets